David Palma
Radiation oncologist and clinician-scientist at the Verspeeten Family Cancer Centre / London Health Sciences Centre and Professor at Western University's Schulich School of Medicine, known for the SABR-COMET oligometastatic cancer trials.
1
APPEARANCES
1
PODCASTS
Sep 2, 2026
RonakHOST
What is the literature surrounding management of these patients? I mean, if they have better overall survivals, can we get away with maybe less radiation or shorter duration of radiation? What is being discussed in the
David PalmaGUEST
And I think there's an interesting probably bias here too among oncologists is that these patients are the ones who I think stereotypically relate more to the treating practitioners.
David PalmaGUEST
I think we're a bit biased for these patients because these are people who are of higher SES.
David PalmaGUEST
And there might be an inherent bias that we're focusing our research on these people who are most like us.
20 MINS LATER
VivekHOST
Is it that sweet or is it overhyped?